New Drug-Resistant Fungal Disease Increases Among Vulnerable Patients in Pa. and Other States

New drug-resistant fungal disease increases among vulnerable patients

Open the article to view the coverage from Louisiana Illuminator

New drug-resistant fungal disease increases among vulnerable patients in Pa. and other states

Open the article to view the coverage from Pennsylvania Capital-Star

Putting β-glucan testing into everyday practice for fungal infections

Invasive fungal infections are notoriously hard to catch early, and even harder to rule out with confidence. At the Parasitology-Mycology Laboratory of CHU Bordeaux, Consultant Physician Dr Frédéric Gabriel has spent years refining how his lab uses β-D-glucan (BDG) testing to sharpen that judgement call – including with the Wako β-glucan test. In this interview, he explains what the guidelines say, what actually happens at the bench, and where he sees the test heading next.